Literature DB >> 28322284

Genomic resources for the study of neuropsychiatric disorders.

G Senthil1, T Dutka1, L Bingaman1, T Lehner1.   

Abstract

The National Institute of Mental Health (NIMH) has made sustained investments in the development of genomic resources over the last two decades. These investments have led to the development of the largest biorepository for psychiatric genetics as a centralized national resource. In the realm of genomic resources, NIMH has been supporting large team science (TS) consortia focused on gene discovery, fine mapping of loci, and functional genomics using state-of-the-art technologies. The scientific output from these efforts has not only begun to transform our understanding of the genetic architecture of neuropsychiatric disorders, but it has also led to a broader cultural change among the investigator community towards deeper collaborations and broad pre-publication sharing of data and resources. The NIMH supported efforts have led to a vast increase in the amount of genetic and genomic resources available to the mental health research community. Here we provide an account of the existing resources and estimates of the scale and scope of what will be available in the near future. All biosamples and data described are intended for broad sharing with researchers worldwide, as allowed by the subject consent and applicable laws.

Entities:  

Mesh:

Year:  2017        PMID: 28322284     DOI: 10.1038/mp.2017.29

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  18 in total

1.  NIMH Human Genetics Initiative: 2003 update.

Authors:  Steven O Moldin
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

Review 2.  A framework for interpreting genome-wide association studies of psychiatric disorders.

Authors: 
Journal:  Mol Psychiatry       Date:  2008-11-11       Impact factor: 15.992

3.  The National Institutes of Health Neurobiobank: a federated national network of human brain and tissue repositories.

Authors:  Lisa Nichols; Michelle Freund; Cathy Ng; Alice Kau; Melissa Parisi; Anna Taylor; David Armstrong; Frank Avenilla; Jeymohan Joseph; Doug Meinecke; Ann Wagner; A Roger Little
Journal:  Biol Psychiatry       Date:  2013-09-25       Impact factor: 13.382

Review 4.  Convergence of advances in genomics, team science, and repositories as drivers of progress in psychiatric genomics.

Authors:  Thomas Lehner; Geetha Senthil; Anjené M Addington
Journal:  Biol Psychiatry       Date:  2014-01-15       Impact factor: 13.382

5.  The autism sequencing consortium: large-scale, high-throughput sequencing in autism spectrum disorders.

Authors:  Joseph D Buxbaum; Mark J Daly; Bernie Devlin; Thomas Lehner; Kathryn Roeder; Matthew W State
Journal:  Neuron       Date:  2012-12-20       Impact factor: 17.173

6.  Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism.

Authors:  Neelroop N Parikshak; Rui Luo; Alice Zhang; Hyejung Won; Jennifer K Lowe; Vijayendran Chandran; Steve Horvath; Daniel H Geschwind
Journal:  Cell       Date:  2013-11-21       Impact factor: 41.582

7.  SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients.

Authors:  Aleksandr Shcheglovitov; Olesya Shcheglovitova; Masayuki Yazawa; Thomas Portmann; Rui Shu; Vittorio Sebastiano; Anna Krawisz; Wendy Froehlich; Jonathan A Bernstein; Joachim F Hallmayer; Ricardo E Dolmetsch
Journal:  Nature       Date:  2013-10-16       Impact factor: 49.962

8.  From the principles of genomic data sharing to the practices of data access committees.

Authors:  Mahsa Shabani; Bartha Maria Knoppers; Pascal Borry
Journal:  EMBO Mol Med       Date:  2015-05       Impact factor: 12.137

9.  Integrated model of de novo and inherited genetic variants yields greater power to identify risk genes.

Authors:  Xin He; Stephan J Sanders; Li Liu; Silvia De Rubeis; Elaine T Lim; James S Sutcliffe; Gerard D Schellenberg; Richard A Gibbs; Mark J Daly; Joseph D Buxbaum; Matthew W State; Bernie Devlin; Kathryn Roeder
Journal:  PLoS Genet       Date:  2013-08-15       Impact factor: 5.917

10.  Biological insights from 108 schizophrenia-associated genetic loci.

Authors: 
Journal:  Nature       Date:  2014-07-22       Impact factor: 49.962

View more
  6 in total

1.  NIMH neuropsychiatric genomics: crucial foundational accomplishments and the extensive challenges that remain.

Authors:  D L Braff
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

2.  Pleiotropic Meta-Analysis of Cognition, Education, and Schizophrenia Differentiates Roles of Early Neurodevelopmental and Adult Synaptic Pathways.

Authors:  Max Lam; W David Hill; Joey W Trampush; Jin Yu; Emma Knowles; Gail Davies; Eli Stahl; Laura Huckins; David C Liewald; Srdjan Djurovic; Ingrid Melle; Kjetil Sundet; Andrea Christoforou; Ivar Reinvang; Pamela DeRosse; Astri J Lundervold; Vidar M Steen; Thomas Espeseth; Katri Räikkönen; Elisabeth Widen; Aarno Palotie; Johan G Eriksson; Ina Giegling; Bettina Konte; Annette M Hartmann; Panos Roussos; Stella Giakoumaki; Katherine E Burdick; Antony Payton; William Ollier; Ornit Chiba-Falek; Deborah K Attix; Anna C Need; Elizabeth T Cirulli; Aristotle N Voineskos; Nikos C Stefanis; Dimitrios Avramopoulos; Alex Hatzimanolis; Dan E Arking; Nikolaos Smyrnis; Robert M Bilder; Nelson A Freimer; Tyrone D Cannon; Edythe London; Russell A Poldrack; Fred W Sabb; Eliza Congdon; Emily Drabant Conley; Matthew A Scult; Dwight Dickinson; Richard E Straub; Gary Donohoe; Derek Morris; Aiden Corvin; Michael Gill; Ahmad R Hariri; Daniel R Weinberger; Neil Pendleton; Panos Bitsios; Dan Rujescu; Jari Lahti; Stephanie Le Hellard; Matthew C Keller; Ole A Andreassen; Ian J Deary; David C Glahn; Anil K Malhotra; Todd Lencz
Journal:  Am J Hum Genet       Date:  2019-08-01       Impact factor: 11.025

Review 3.  Stem Cells, Genome Editing, and the Path to Translational Medicine.

Authors:  Frank Soldner; Rudolf Jaenisch
Journal:  Cell       Date:  2018-10-18       Impact factor: 41.582

4.  Sequence Variation Associated with SLC12A5 Gene Expression Is Linked to Brain Structure and Function in Healthy Adults.

Authors:  Michael D Gregory; J Shane Kippenhan; Joseph H Callicott; Daniel Y Rubinstein; Venkata S Mattay; Richard Coppola; Karen F Berman
Journal:  Cereb Cortex       Date:  2019-12-17       Impact factor: 5.357

Review 5.  Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders.

Authors:  Trang T T Truong; Bruna Panizzutti; Jee Hyun Kim; Ken Walder
Journal:  Pharmaceutics       Date:  2022-07-14       Impact factor: 6.525

Review 6.  A framework for the investigation of rare genetic disorders in neuropsychiatry.

Authors:  Stephan J Sanders; Mustafa Sahin; Joseph Hostyk; Audrey Thurm; Sebastien Jacquemont; Paul Avillach; Elise Douard; Christa L Martin; Meera E Modi; Andres Moreno-De-Luca; Armin Raznahan; Alan Anticevic; Ricardo Dolmetsch; Guoping Feng; Daniel H Geschwind; David C Glahn; David B Goldstein; David H Ledbetter; Jennifer G Mulle; Sergiu P Pasca; Rodney Samaco; Jonathan Sebat; Anne Pariser; Thomas Lehner; Raquel E Gur; Carrie E Bearden
Journal:  Nat Med       Date:  2019-09-23       Impact factor: 53.440

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.